IL66070A - Compositions for topically treating glaucoma comprising aryloxypropanolamine derivatives - Google Patents

Compositions for topically treating glaucoma comprising aryloxypropanolamine derivatives

Info

Publication number
IL66070A
IL66070A IL66070A IL6607082A IL66070A IL 66070 A IL66070 A IL 66070A IL 66070 A IL66070 A IL 66070A IL 6607082 A IL6607082 A IL 6607082A IL 66070 A IL66070 A IL 66070A
Authority
IL
Israel
Prior art keywords
alkenyl
lower alkyl
alkynyl
treating glaucoma
hydroxyloweralkyl
Prior art date
Application number
IL66070A
Other languages
English (en)
Other versions
IL66070A0 (en
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of IL66070A0 publication Critical patent/IL66070A0/xx
Publication of IL66070A publication Critical patent/IL66070A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL66070A 1981-06-23 1982-06-16 Compositions for topically treating glaucoma comprising aryloxypropanolamine derivatives IL66070A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,658 US4454154A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (2)

Publication Number Publication Date
IL66070A0 IL66070A0 (en) 1982-09-30
IL66070A true IL66070A (en) 1987-03-31

Family

ID=23057573

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66070A IL66070A (en) 1981-06-23 1982-06-16 Compositions for topically treating glaucoma comprising aryloxypropanolamine derivatives

Country Status (17)

Country Link
US (1) US4454154A (de)
EP (1) EP0082873B1 (de)
JP (1) JPH0653663B2 (de)
AU (1) AU565752B2 (de)
CA (1) CA1188224A (de)
CH (1) CH654205A5 (de)
ES (1) ES8401928A1 (de)
GB (1) GB2111387B (de)
GR (1) GR76847B (de)
IL (1) IL66070A (de)
IT (1) IT1156058B (de)
NL (1) NL8220252A (de)
NZ (1) NZ200972A (de)
PH (1) PH18970A (de)
SE (1) SE462075B (de)
WO (1) WO1983000014A1 (de)
ZA (1) ZA824340B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
DE3871596T3 (de) * 1987-04-03 2000-09-07 Pharmacia & Upjohn Ab, Stockholm Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes.
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
WO2005115375A1 (en) * 2004-05-25 2005-12-08 Othera Pharmaceuticals, Inc. Oculoselective drugs and prodrugs

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 (de) * 1971-04-09 1974-08-02 Lipha
JPS4875539A (de) * 1972-01-12 1973-10-11
JPS49247A (de) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0003664B1 (de) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolaminderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
AU8737482A (en) 1983-01-18
EP0082873A4 (de) 1983-11-11
NL8220252A (nl) 1983-05-02
CA1188224A (en) 1985-06-04
NZ200972A (en) 1986-10-08
CH654205A5 (de) 1986-02-14
JPH0653663B2 (ja) 1994-07-20
GB2111387A (en) 1983-07-06
AU565752B2 (en) 1987-09-24
PH18970A (en) 1985-11-26
IT1156058B (it) 1987-01-28
IT8267796A0 (it) 1982-06-22
SE462075B (sv) 1990-05-07
IL66070A0 (en) 1982-09-30
GB2111387B (en) 1986-02-05
SE8300913L (en) 1983-02-18
ES513387A0 (es) 1984-01-01
GR76847B (de) 1984-09-04
EP0082873A1 (de) 1983-07-06
GB8303061D0 (en) 1983-03-09
JPS58500996A (ja) 1983-06-23
WO1983000014A1 (en) 1983-01-06
SE8300913D0 (sv) 1983-02-18
US4454154A (en) 1984-06-12
ES8401928A1 (es) 1984-01-01
EP0082873B1 (de) 1988-12-07
ZA824340B (en) 1983-04-27

Similar Documents

Publication Publication Date Title
IL66070A (en) Compositions for topically treating glaucoma comprising aryloxypropanolamine derivatives
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
IE810236L (en) Sulfamoyl derivatives.
ATE207360T1 (de) Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
EP0028833A3 (en) Imidazole derivatives, their production and use
ES2071227T3 (es) Composicion para gotas para los ojos.
DE3782929D1 (de) Bearbeitungsverfahren mittels laserstrahles.
CA2019974A1 (en) Treatment of inflammation
CA2274819A1 (en) Method for treating cellulosic shaped bodies
NO912646L (no) Opploesning av cellulose i vann og n-metyl-morfolin-n-oksyd
ES8401927A1 (es) Procedimiento de obtencion de composiciones oftalmologicas.
PT90022A (pt) Processo para a preparacao de derivados cefem e dos intermediarios correspondentes
FI911131A0 (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
IE40068L (en) 1, 4- dihydro -h- isoquinolines
BR9709916A (pt) Processo para o tratamento de fibras de celulose e de conjuntos feitos destas fibras
ATE57095T1 (de) Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks.
ATE132750T1 (de) Behandlung von intraokularem druck mit einer synergischen kombination
AU2149888A (en) Novel benzimidazole derivatives
DE2961723D1 (en) Protecting solution for heart and kidneys and process for its manufacture
ES8405358A1 (es) Procedimiento de obtencion de agentes de beta bloqueantes conteniendo grupos de ester con propiedades oftalmologicas.
SE8300914D0 (sv) Kompositioner for behandling av glaukom
AR246958A1 (es) Procedimiento para preparar 1-hidroximetilpirazol.
JPS6448693A (en) Laser beam machine
NZ335566A (en) 3-amino-propoxyphenyl derivatives (I) and use in treating cardiac conditions as a beta blocker
FR2457338A1 (fr) Procede pour la protection des matieres cellulosiques au cours de leurs traitements par des solutions alcalines